The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

This project aims to predict cellular activity using deep learning techniques from spatial transcriptomics data. We integrate single-cell RNA-seq data and spatially-resolved transcriptomics data ...

Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

"This development further validates the strength of our broad patent portfolio, which helps protect and preserve the world-class innovation engine at 10x," said Eric S. Whitaker, Chief Legal ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ — 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

This year’s list of biotech companies reflects the evolving impact of AI, a growing interest in cutting-edge research tools for single-cell analysis and spatial proteomics, and clinical advances ...

Three key investors have left General Catalyst amidst a series of recent changes at the firm, which now describes itself as an “investment and transformation company,” TechCrunch has learned.